Michael F. Weaver

3.2k total citations
71 papers, 2.4k citations indexed

About

Michael F. Weaver is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Michael F. Weaver has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 18 papers in Public Health, Environmental and Occupational Health and 14 papers in Epidemiology. Recurrent topics in Michael F. Weaver's work include Smoking Behavior and Cessation (21 papers), Opioid Use Disorder Treatment (12 papers) and Pain Management and Opioid Use (11 papers). Michael F. Weaver is often cited by papers focused on Smoking Behavior and Cessation (21 papers), Opioid Use Disorder Treatment (12 papers) and Pain Management and Opioid Use (11 papers). Michael F. Weaver collaborates with scholars based in United States, Lebanon and Japan. Michael F. Weaver's co-authors include Thomas Eissenberg, Caroline O. Cobb, Andrea R. Vansickel, Sidney H. Schnoll, Alan Shihadeh, Karen L. Cropsey, Melissa D. Blank, Maxine L. Stitzer, John A. Hopper and Erik W. Gunderson and has published in prestigious journals such as American Journal of Psychiatry, Brain Research and American Journal of Public Health.

In The Last Decade

Michael F. Weaver

66 papers receiving 2.3k citations

Peers

Michael F. Weaver
Philipe de Souto Barreto France
Pirjo Halonen Finland
Valory Pavlik United States
Mariann R. Piano United States
Mori J. Krantz United States
Pekka Mäntyselkä Finland
Abu Minhajuddin United States
Patricia Schofield United Kingdom
Hanna Kaduszkiewicz Germany
Reginald V. Fant United States
Philipe de Souto Barreto France
Michael F. Weaver
Citations per year, relative to Michael F. Weaver Michael F. Weaver (= 1×) peers Philipe de Souto Barreto

Countries citing papers authored by Michael F. Weaver

Since Specialization
Citations

This map shows the geographic impact of Michael F. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Weaver more than expected).

Fields of papers citing papers by Michael F. Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Weaver. The network helps show where Michael F. Weaver may publish in the future.

Co-authorship network of co-authors of Michael F. Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Weaver. A scholar is included among the top collaborators of Michael F. Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Weaver. Michael F. Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schmitz, Joy M., Angela L. Stotts, Anka A. Vujanovic, et al.. (2024). Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART). Drug and Alcohol Dependence. 256. 111078–111078. 2 indexed citations
3.
4.
5.
Weaver, Michael F.. (2022). Concerns About Hospital-based Managed Alcohol Programs. Journal of Addiction Medicine. 17(2). 129–130.
6.
Yoon, Jin H., Robert Suchting, Anka A. Vujanovic, et al.. (2019). Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.. Psychology of Addictive Behaviors. 34(1). 164–174. 16 indexed citations
7.
Tong, Sebastian T., et al.. (2019). Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments. The Journal of the American Board of Family Medicine. 32(2). 272–278. 3 indexed citations
8.
Suchting, Robert, Jin H. Yoon, Charles E. Green, et al.. (2019). Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder. Brain Research. 1731. 146359–146359. 43 indexed citations
9.
Weaver, Michael F., et al.. (2018). Management of chronic nonmalignant pain: A needs assessment in an Internal Medicine Resident Continuity Clinic. Journal of Opioid Management. 4(4). 201–211. 10 indexed citations
10.
Weaver, Michael F., John A. Hopper, & Erik W. Gunderson. (2015). Designer drugs 2015: assessment and management. Addiction Science & Clinical Practice. 10(1). 8–8. 97 indexed citations
11.
Breland, Alison, et al.. (2014). Targeting tobacco in a community-based addiction recovery cohort: Results from a computerized, brief, randomized intervention trial. Contemporary Clinical Trials. 38(1). 113–120. 11 indexed citations
12.
Cropsey, Karen L., et al.. (2009). Differential success rates in racial groups: Results of a clinical trial of smoking cessation among female prisoners. Nicotine & Tobacco Research. 11(6). 690–697. 38 indexed citations
13.
Blank, Melissa D., et al.. (2008). Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine & Tobacco Research. 10(3). 417–421. 29 indexed citations
14.
Gray, Jennifer, Alison Breland, Michael F. Weaver, & Thomas Eissenberg. (2008). Potential reduced exposure products (PREPs) for smokeless tobacco users: Clinical evaluation methodology. Nicotine & Tobacco Research. 10(9). 1441–1448. 21 indexed citations
15.
Kleykamp, Bethea A., et al.. (2008). The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.. Experimental and Clinical Psychopharmacology. 16(2). 99–112. 22 indexed citations
16.
Evans, Sarah E., et al.. (2006). Transdermal nicotine-induced tobacco abstinence symptom suppression: Nicotine dose and smokers' gender.. Experimental and Clinical Psychopharmacology. 14(2). 121–135. 52 indexed citations
17.
Weaver, Michael F.. (2006). Malignant pain or malignant patients?. Journal of Opioid Management. 2(5). 259–261. 4 indexed citations
18.
Weaver, Michael F. & Sidney H. Schnoll. (2002). Opioid Treatment of Chronic Pain in Patients with Addiction. Journal of Pain & Palliative Care Pharmacotherapy. 16(3). 5–26. 42 indexed citations
19.
Eissenberg, Thomas, et al.. (2000). A clinical laboratory model for direct assessment of medication-induced antihyperalgesia and subjective effects: Initial validation study.. Experimental and Clinical Psychopharmacology. 8(1). 47–60. 5 indexed citations
20.
Crisp, Terriann, et al.. (1991). Serotonin contributes to the spinal antinociceptive effects of morphine. Pharmacology Biochemistry and Behavior. 39(3). 591–595. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipe de Souto Barreto Breakdown of academic impact, for papers by Pirjo Halonen Breakdown of academic impact, for papers by Valory Pavlik Breakdown of academic impact, for papers by Mariann R. Piano Breakdown of academic impact, for papers by Mori J. Krantz Breakdown of academic impact, for papers by Pekka Mäntyselkä Breakdown of academic impact, for papers by Abu Minhajuddin Breakdown of academic impact, for papers by Patricia Schofield Breakdown of academic impact, for papers by Hanna Kaduszkiewicz Breakdown of academic impact, for papers by Reginald V. Fant
Rankless by CCL
2026